Skip to main content

Table 3 Proportions of cancers and genital warts attributable to HPV infection

From: Estimating the cost-effectiveness profile of a universal vaccination programme with a nine-valent HPV vaccine in Austria

 

Female

Male

 

4-valent vaccination

9-valent vaccination

4-valent vaccination

9-valent vaccination

Cervical cancer

72.8 %

89.0 %

–

–

Vaginal

50.7 %

60.6 %

–

–

Vulvar

14.2 %

16.2 %

–

–

Anal

76.3 %

78.7 %

76.3 %

78.7 %

Penile

–

–

34.4 %

34.4 %

Head and Neck

13.6 %

13.6 %

16.5 %

16.5 %

Genital warts

90 %

90 %

90 %

90 %

  1. Source: Hartwig (2015) [4]
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us